We are very proud to share our last piece published in the March issue of the Lancet Oncology The article entitled "Access to new drugs in paediatric oncology: can we learn from the ongoing ONC201 saga?" has been written by Nicolas André from the Department of Pediatric Oncology, La Timone University, Hospital of Marseille, APHM, Marseille 13005, France; Guy Buyens from the The Anticancer Fund, Brussels, Belgium; Eric Bouffet from the Division of Neuro-oncology,Department of Pediatric (...)